Link
Table of contents http://www.loc.gov/catdir/toc/ucal041/2003063422.html
Publisher description http://www.loc.gov/catdir/description/ucal042/2003063422.html
Notes
Includes bibliographical references (p. 281-283) and index.
Abstract
"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and live-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government’s role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket.
ISBN
0520239458 (hbk. : alk. paper)
0520246705
Subject
Prescription pricing. Drugs -- Prices. Pharmaceutical industry. Consumer education. Pharmaceutical industry -- economics. Medicine -- Research. Chemotherapy -- economics.
